Empagliflozin reduces albuminuria-a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial

Rikke Borg, Frederik Persson

OriginalsprogEngelsk
TidsskriftAnnals of Translational Medicine
Vol/bind5
Udgave nummer23
Sider (fra-til)478
ISSN2305-5839
DOI
StatusUdgivet - dec. 2017

Citationsformater